Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 34.00
-0.75 (-2.16%)
At close: Aug 18, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.97 billion as of August 18, 2026. Its market cap has decreased by -1.08% in one year.
Market Cap
4.97B
Enterprise Value
7.15B
Revenue
8.54B
Ranking
n/a
PE Ratio
11.29
Stock Price
34.00
ChartMarket Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.97B, a decrease of -19.93%. That is a compound annual growth rate of -10.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 4.97B | 1.75% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 621.65B |
| Caliway Biopharmaceuticals | 161.76B |
| Lin BioScience | 75.54B |
| Pell Bio-Med Technology | 69.33B |
| Orient Pharma | 5.34B |
| Steminent Biotherapeutics | 5.27B |
| CHC Healthcare Group | 5.20B |
| AnnJi Pharmaceutical | 5.16B |